Arkolith/Insider Trading/EDIT/Form 4

Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICEREditas Medicine, Inc. (EDIT) · full profile →Form 4 · filed Mar 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2024Grant(A)25K—$070K
Mar 2, 2024Grant(A)15K—$085K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2024Grant(A)74K—$074K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001650664-24-000017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML